Sola Biosciences LLC
Sola Biosciences LLC, based in Natick, MA, is dedicated to developing gene therapies for patients suffering from neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Huntington's disease (HD). Their innovative Engineered Targeting Chaperone Platform Technology, known as JUMP70, aims to harness the power of a patient's own chaperones to repair misfolded proteins that contribute to these conditions.
The company is actively working on multiple clinical candidates, including SOL257, which targets pathogenic TDP-43 to potentially delay disease progression and extend lifespan in ALS model animals. Collaborating with esteemed researchers, medical professionals, and investors, Sola Biosciences strives to make their groundbreaking therapies available to patients and their families as quickly as possible.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.